Injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in NIH study. The drug already approved to treat other complications of HIV, may be effective in addressing non-alcoholic fatty liver disease.
from Medindia Health News https://ift.tt/2M8tSJJ
No comments:
Post a Comment